Annual Net Income
-$67.00 M
-$42.51 M-173.59%
December 31, 2023
Summary
- As of February 8, 2025, VRCA annual net profit is -$67.00 million, with the most recent change of -$42.51 million (-173.59%) on December 31, 2023.
- During the last 3 years, VRCA annual net income has fallen by -$24.30 million (-56.92%).
- VRCA annual net income is now -3402.09% below its all-time high of -$1.91 million, reached on December 31, 2016.
Performance
VRCA Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$22.86 M
-$5.67 M-33.02%
September 30, 2024
Summary
- As of February 8, 2025, VRCA quarterly net profit is -$22.86 million, with the most recent change of -$5.67 million (-33.02%) on September 30, 2024.
- Over the past year, VRCA quarterly net income has increased by +$1.94 million (+7.83%).
- VRCA quarterly net income is now -27642.17% below its all-time high of $83.00 thousand, reached on September 30, 2022.
Performance
VRCA Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$84.99 M
+$1.94 M+2.23%
September 30, 2024
Summary
- As of February 8, 2025, VRCA TTM net profit is -$84.99 million, with the most recent change of +$1.94 million (+2.23%) on September 30, 2024.
- Over the past year, VRCA TTM net income has dropped by -$36.68 million (-75.92%).
- VRCA TTM net income is now -14810.70% below its all-time high of -$570.00 thousand, reached on March 31, 2017.
Performance
VRCA TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
VRCA Net Income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -173.6% | +7.8% | -75.9% |
3 y3 years | -56.9% | -285.4% | -247.1% |
5 y5 years | -224.5% | -285.4% | -247.1% |
VRCA Net Income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -173.6% | at low | <-9999.0% | +7.8% | -276.0% | +2.2% |
5 y | 5-year | -173.6% | at low | <-9999.0% | +7.8% | -276.0% | +2.2% |
alltime | all time | -3402.1% | at low | <-9999.0% | +7.8% | <-9999.0% | +2.2% |
Verrica Pharmaceuticals Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$22.86 M(+33.0%) | -$84.99 M(-2.2%) |
Jun 2024 | - | -$17.19 M(-15.5%) | -$86.93 M(+7.7%) |
Mar 2024 | - | -$20.33 M(-17.4%) | -$80.74 M(+20.5%) |
Dec 2023 | -$67.00 M(+173.6%) | -$24.61 M(-0.8%) | -$67.00 M(+38.7%) |
Sep 2023 | - | -$24.80 M(+125.7%) | -$48.31 M(+106.2%) |
Jun 2023 | - | -$10.99 M(+66.8%) | -$23.43 M(+3.6%) |
Mar 2023 | - | -$6.59 M(+11.1%) | -$22.61 M(-7.7%) |
Dec 2022 | -$24.49 M(-30.2%) | -$5.93 M(-7247.0%) | -$24.49 M(-12.8%) |
Sep 2022 | - | $83.00 K(-100.8%) | -$28.09 M(-31.5%) |
Jun 2022 | - | -$10.17 M(+20.0%) | -$41.01 M(-3.8%) |
Mar 2022 | - | -$8.47 M(-11.2%) | -$42.61 M(+21.5%) |
Dec 2021 | -$35.08 M(-17.8%) | -$9.54 M(-25.6%) | -$35.08 M(-8.9%) |
Sep 2021 | - | -$12.83 M(+9.0%) | -$38.52 M(+6.5%) |
Jun 2021 | - | -$11.78 M(+1158.0%) | -$36.17 M(+7.0%) |
Mar 2021 | - | -$936.00 K(-92.8%) | -$33.81 M(-20.8%) |
Dec 2020 | -$42.69 M | -$12.98 M(+23.8%) | -$42.69 M(+14.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2020 | - | -$10.49 M(+11.4%) | -$37.35 M(+13.3%) |
Jun 2020 | - | -$9.41 M(-4.2%) | -$32.96 M(+7.9%) |
Mar 2020 | - | -$9.82 M(+28.6%) | -$30.55 M(+8.3%) |
Dec 2019 | -$28.21 M(+36.6%) | -$7.64 M(+25.4%) | -$28.21 M(+0.2%) |
Sep 2019 | - | -$6.09 M(-13.0%) | -$28.15 M(+0.7%) |
Jun 2019 | - | -$7.00 M(-6.4%) | -$27.96 M(+6.4%) |
Mar 2019 | - | -$7.48 M(-1.3%) | -$26.28 M(+27.3%) |
Dec 2018 | -$20.65 M(+363.1%) | -$7.58 M(+28.3%) | -$20.65 M(+42.4%) |
Sep 2018 | - | -$5.91 M(+11.1%) | -$14.51 M(+45.7%) |
Jun 2018 | - | -$5.32 M(+187.9%) | -$9.96 M(+73.6%) |
Mar 2018 | - | -$1.85 M(+28.7%) | -$5.74 M(+28.6%) |
Dec 2017 | -$4.46 M(+133.1%) | -$1.44 M(+5.6%) | -$4.46 M(+47.5%) |
Sep 2017 | - | -$1.36 M(+24.1%) | -$3.02 M(+81.6%) |
Jun 2017 | - | -$1.09 M(+92.1%) | -$1.67 M(+192.1%) |
Mar 2017 | - | -$570.00 K | -$570.00 K |
Dec 2016 | -$1.91 M | - | - |
FAQ
- What is Verrica Pharmaceuticals annual net profit?
- What is the all time high annual net income for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals annual net income year-on-year change?
- What is Verrica Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals quarterly net income year-on-year change?
- What is Verrica Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Verrica Pharmaceuticals?
- What is Verrica Pharmaceuticals TTM net income year-on-year change?
What is Verrica Pharmaceuticals annual net profit?
The current annual net income of VRCA is -$67.00 M
What is the all time high annual net income for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high annual net profit is -$1.91 M
What is Verrica Pharmaceuticals annual net income year-on-year change?
Over the past year, VRCA annual net profit has changed by -$42.51 M (-173.59%)
What is Verrica Pharmaceuticals quarterly net profit?
The current quarterly net income of VRCA is -$22.86 M
What is the all time high quarterly net income for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high quarterly net profit is $83.00 K
What is Verrica Pharmaceuticals quarterly net income year-on-year change?
Over the past year, VRCA quarterly net profit has changed by +$1.94 M (+7.83%)
What is Verrica Pharmaceuticals TTM net profit?
The current TTM net income of VRCA is -$84.99 M
What is the all time high TTM net income for Verrica Pharmaceuticals?
Verrica Pharmaceuticals all-time high TTM net profit is -$570.00 K
What is Verrica Pharmaceuticals TTM net income year-on-year change?
Over the past year, VRCA TTM net profit has changed by -$36.68 M (-75.92%)